[go: up one dir, main page]

ES2722673A1 - Aqueous ranitidine solution (Machine-translation by Google Translate, not legally binding) - Google Patents

Aqueous ranitidine solution (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES2722673A1
ES2722673A1 ES201800035A ES201800035A ES2722673A1 ES 2722673 A1 ES2722673 A1 ES 2722673A1 ES 201800035 A ES201800035 A ES 201800035A ES 201800035 A ES201800035 A ES 201800035A ES 2722673 A1 ES2722673 A1 ES 2722673A1
Authority
ES
Spain
Prior art keywords
translation
machine
legally binding
google translate
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201800035A
Other languages
Spanish (es)
Other versions
ES2722673B2 (en
Inventor
Menendez Nuria Sanz
Cordoba Raquel Horcajada
Calvo Antonia Gomez
De La Torre Marta Vicario
Garcia Jose Angel Sanchez
Serna Luis Sante
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Priority to ES201800035A priority Critical patent/ES2722673B2/en
Publication of ES2722673A1 publication Critical patent/ES2722673A1/en
Application granted granted Critical
Publication of ES2722673B2 publication Critical patent/ES2722673B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to an aqueous solution of ranitidine, which is free of ethanol, and the same for use in the prevention and/or treatment of duodenal and gastric ulcer, prevention and/or treatment of gastrointestinal bleeding and treatment. of peptic esophagitis. The solution is particularly suitable for administration to patients under 3 years old. This solution comprises a taste masking system based on glycerin and/or sorbitol, and a preservative system that gives it good stability despite having a high content of principle active. (Machine-translation by Google Translate, not legally binding)
ES201800035A 2018-02-12 2018-02-12 Aqueous ranitidine solution Active ES2722673B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201800035A ES2722673B2 (en) 2018-02-12 2018-02-12 Aqueous ranitidine solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201800035A ES2722673B2 (en) 2018-02-12 2018-02-12 Aqueous ranitidine solution

Publications (2)

Publication Number Publication Date
ES2722673A1 true ES2722673A1 (en) 2019-08-14
ES2722673B2 ES2722673B2 (en) 2021-03-29

Family

ID=67540186

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201800035A Active ES2722673B2 (en) 2018-02-12 2018-02-12 Aqueous ranitidine solution

Country Status (1)

Country Link
ES (1) ES2722673B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
WO2009008895A1 (en) * 2007-07-09 2009-01-15 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
WO2009008895A1 (en) * 2007-07-09 2009-01-15 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation

Also Published As

Publication number Publication date
ES2722673B2 (en) 2021-03-29

Similar Documents

Publication Publication Date Title
SA522431866B1 (en) Receptor-interacting protein 1 inhibitory compounds and methods for making and using the same
ZA202103587B (en) Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors
SA522440778B1 (en) .rip1k inhibitors
EA202092580A1 (en) RIP1 INHIBITING COMPOUNDS AND METHODS FOR THEIR PREPARATION AND APPLICATION
MX2017012507A (en) Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same.
RU2015141767A (en) Compositions and methods for the local delivery of prostaglandins to subcutaneous fat
MX2020001403A (en) Quinoline derivatives for treating infections with helminths.
JOP20220056A1 (en) RIP1 inhibitory compounds, modes of action and use
BR112017007708A2 (en) macrocyclic compound, use of a macrocyclic compound, method of treatment, unit dose, pharmaceutical composition and method of treating cancer in a patient
MX2021001807A (en) Combination of histone deacetylase inhibitor and protein kinase inhibitor and pharmaceutical use thereof.
TN2017000271A1 (en) Glucagon derivative having improved stability
EA202090069A1 (en) COMPOSITION FOR USE IN PREVENTION AND TREATMENT OF CARDIOVASCULAR SYSTEM PATHOLOGIES
EA202091446A1 (en) METHODS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES
MX2019010218A (en) Pyrazole derivatives as bromodomain inhibitors.
ES2722673A1 (en) Aqueous ranitidine solution (Machine-translation by Google Translate, not legally binding)
AU2018258588A8 (en) Inhibitors of TRIM33 and methods of use
MX2025006240A (en) Pharmaceutical composition for prevention or treatment of drug-related peptic ulcer comprising zastaprazan or pharmaceutically acceptable salt thereof
EA202090445A1 (en) ANTIFUNGIC AGENTS WITH INCREASED ACTIVITY AT ACID pH
EA201790453A2 (en) NEW SALT OF THE ACCESSION OF ACID 1- (5- (2,4-DIFTORFENYL) -1 - ((3-FLUORPHENYL) SULFONILE) -4-METHOXY-1H-PYRROL-3-IL) -N-METHYLMETHANAMINE
EA201890477A1 (en) INCAPSULATED COMPOSITION OF FINGOLIMODA
EA201791191A1 (en) WATER PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION IN THE ORAL CAVITY CONTAINING FLURBIPROPHENE AND DEXPANTENOL
PH12018000227B1 (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
RO130546A3 (en) Ointment for treatment of hemorrhoidal disease
CY1123924T1 (en) NEW CIGARETTE FILTER CONTAINING ALGINITE
DE602006007538D1 (en) TASTE SUPPRESSION SYSTEM FOR NON-WEIGHTED MEDICINAL PRODUCTS

Legal Events

Date Code Title Description
BA2A Patent application published

Ref document number: 2722673

Country of ref document: ES

Kind code of ref document: A1

Effective date: 20190814

FG2A Definitive protection

Ref document number: 2722673

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20210329